Between the ages of 18 and 75 years old
You experienced at least 3 HAE attacks in the last 4 months, or at least 2 HAE attacks in the last 2 months
You are familiar with using medication for managing HAE attacks
Able and willing to use an electronic diary (training will be provided)
Researchers developed the study drug in the form of soft capsules taken by mouth, which are expected to be a more convenient alternative to an injection into a vein or under the skin for resolving HAE attacks.
Contact a study location near you and contact your HCP.
Visit the study location and receive more information.
Review and sign an informed consent form.
Conduct a screening visit where you will have study tests and procedures to confirm if you can be in the RAPIDe-1 clinical research study.
Enroll in RAPIDe-1 study, lasting approximately 7 months.